FDA To Continue Use Of Remote Assessments After Pandemic

By Gabrielle Wanneh / July 25, 2022 at 4:30 PM
FDA plans to continue using remote regulatory assessments (RRAs) after the public health emergency ends because, although they were used to allow for some level of inspection during lock-downs, the agency believes RRAs would also make better use of inspectors’ time during normal inspections, according to draft guidance published Friday (July 22). They also could be used to complement inspections by regulators from other countries. Although FDA is for now making do with guidance, which isn’t legally binding, Pharmaceutical Research...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.